2014 ACR/ARHP Annual Meeting Archives - Page 122 of 202

Abstract Number: 2727

T Cells Trigger Interstitial Pneumonia in Polymyositis
Abstract Number: 2848

T-Cell Signaling Defects Can be Corrected By Manipulating ‘TCR Signal Fine-Tuning Molecules’ That Are Altered Due to Increased Ubiquitination in Systemic Autoimmune Disease
Abstract Number: 1735

T–cell Tolerance Induction By the Glycosylated Type II Collagen Peptide-Based Vaccination in Murine Arthritis
Abstract Number: 1970

T_H17 Inflammatory Responses Occur in a Subset of Patients with Erythema Migrans or Lyme Arthritis, but Are Not Predominant Responses in Joints
Abstract Number: 1139

TACR1 rs3771863 Single Nucleotide Polymorphism Is a Genetic Risk Factor for Sicca Syndrome in Fibromyalgia Patients
Abstract Number: 325

Tadalafil Decreases Joint Inflammation in TNF-Tg Mice By Restoring Passive Lymphatic Transport
Abstract Number: 2431

Tai Chi and Yoga Are Effective for Improving Physical Function in Adults with Rheumatoid Arthritis- a Meta-Analysis
Abstract Number: 805

Takayasu Arteritis and Ulcerative Colitis –High Concurrence Ratio and Genetic Overlap
Abstract Number: 719

Target Modulation of a Type I Interferon (IFN) Gene Signature with Sifalimumab or Anifrolumab in Systemic Lupus Erythematosus (SLE) Patients in Two Open Label Phase 2 Japanese Trials
Abstract Number: 167

Target Serum Urate: Do Patients Know Their Goal?
Abstract Number: 1944

Targeting CD22 with Epratuzumab Impacts Cytokine Production By B Cells
Abstract Number: 935

Targeting Glycolysis in Rheumatoid Arthritis
Abstract Number: 3001

Targeting IL-6 By Both Passive or Active Immunization Strategies Prevents Inflammation-Driven Skin Fibrosis
Abstract Number: 2458

Targeting IL-6, JAK or SYK? : An Analysis of Transcriptome Alteration in Peripheral Blood By RA Treatments
Abstract Number: 2169

Targeting ITGAM+ Cells Successfully Treats a Model of Anti-RNP-Associated Pulmonary Hypertension
Abstract Number: 850

Targeting Synovial Mast Cells in Spondyloarthritis: A Proof-of-Concept Study with the Tyrosine Kinase Inhibitor Nilotinib
Abstract Number: 1019

Targeting the Bone-Driven Metabolic OA Phenotype By a Novel Dual Amylin Calcitonin Receptor Agonist, KBP-056
Abstract Number: 2840

Targeting the RhoA-Rock Pathway to Reverse T Cell Dysfunction in SLE
Abstract Number: 2311

Tele-Rheumatology: Despite Improved Access Could There be a Potential Delay in Care without a Skilled “Presenter”?
Abstract Number: 782

Temporal Artery Microbiome in Giant Cell Arteritis
Abstract Number: 2502

Ten Year Follow-up Results of Four Dynamic Treat to Target Strategies in Patients with ACPA Negative Rheumatoid Arthritis
Abstract Number: 2685

Ten-Eleven Translocation 2 Protein Down-Regulates DNA Methylation of Interleukin-17A Promoter and Induces Its Expression in CD4⁺t Cells of Patients with Systemic Lupus Erythematosus
Abstract Number: 308

Tenascin-C, a TLR4 Ligand Levels in Enthesitis Related Arthritis Category of Juvenile Idiopathic Arthritis: Cross-Sectional and Longitudinal Study
Abstract Number: 1045

Tertiary Lymphoid Organ Developmental Program: Diversgent Paradigm of Lymphoid Organogenesis
Abstract Number: 890

Test of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) 29-Item Profile in a Large Cohort of Rheumatic Disease Patients
Abstract Number: 3018

Testing of a Newly Developed Computerized Animated Activity Questionnaire for Assessing Activity Limitations in Patients with Hip and Knee Osteoarthritis
Abstract Number: 859

TGF-β3-Producing CD4⁺CD25^–LAG3⁺ Regulatory T Cells Control B Cell Responses
Abstract Number: 2731

Th1 and Th17 Cytokines Drive Takayasu Arteritis Inflammation
Abstract Number: 1622

Th1 and Th2 Cytokines Are Associated with Cerebral Atrophy in Systemic Lupus Erythematosus
Abstract Number: 1602

Th9 Cells in Inflammatory Cascades of Autoimmune Arthritis
Abstract Number: 397

Th9 Lymphocytes in Rheumatoid Arthritis
Abstract Number: 958

The 10-Year Followup of a Trial Comparing Azathioprine and Mycophenolate Mofetil for Long-term Immunosuppression of Lupus Nephritis
Abstract Number: 2383

The 12-Years Retention Rate of the First-Line TNF-Inhibitor in the Treatment of Rheumatoid Arthritis: Real-Life Data from a Local Registry
Abstract Number: 1442

The 2013 ACC/AHA Cardiovascular Risk Prediction Model and Coronary Atherosclerosis in Patients with Rheumatoid Arthritis
Abstract Number: 336

The Additive Inflammatory in Vivo and in Vitro Effects of Thymic Stromal Lymphopoietin (TSLP) and IL-7 in Arthritis Underscore the Therapeutic Rationale for blockade of Their Common Receptor Subunit
Abstract Number: 1692

The Additive Value of Nailfold Videocapillaroscopy Patterns to Disease-Specific Autoantibodies in Discrimination of Patients with Systemic Sclerosis at Risk for Severe Organ Involvement
Abstract Number: 991

The Alternative CD20 Transcript Variant Is Not a Factor for Resistance to Rituximab in Patients with Rheumatoid Arthritis
Abstract Number: 2954

The Amino Acid Positions 11, 13 and 26 of HLA-DR Beta Chain 1 Explain the Majority of the Association Between Systemic Lupus Erythematosus and the Major Histocompatibility Complex Locus
Abstract Number: 613

The Amount of Free Heavy Chain and β2-Microglobulin in the Cytoplasm of B*2705 Ankylosing Spondylitis Patients Compared to B*2705 and B*2709 Healthy Subjects Does Not Support the UPR Theory. Influence of ERAP1 Polymorphisms
Abstract Number: 2577

The Ankylosing Spondylitis Disease Activity Score More Closely Reflects MRI Parameters of Sacroiliitis Than the Bath Ankylosing Spondylitis Disease Activity Index in Patients with Non-Radiographic Axial Spondyloarthritis
Abstract Number: 759

The Anti-Fibrotic Effect of Endostatin-Derived Peptide Is Mediated By Urokinase
Abstract Number: 439

The Anti-IL-6 Antibody Sirukumab Inhibits Vascular Inflammation in a Human Surrogate Model of Atherosclerosis
Abstract Number: 2089

The APOL1 Gene Is Not Associated with Lupus Nephritis in Individuals with Enriched Amerindian Ancestry
Abstract Number: 2198

The Aromatase Inhibitor Induced Musculoskeletal Syndrome: Is There a Potential Role of Osteoporosis Therapy and Menopause Timing?
Abstract Number: 2946

The Association Between Accelerometer Monitored Sedentary Behavior and Observed Physical Function Loss
Abstract Number: 2889

The Association Between Changes in Inflammation and High Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis
Abstract Number: 72

The Association Between Doctor-Diagnosed Arthritis and Falls and Fall Injuries Among Middle-Aged and Older Adults
Abstract Number: 1846

The Association Between Hydroxychloroquine Treatment and Cardiovascular Morbidity Among Rheumatoid Arthritis Patients
Abstract Number: 186

The Association Between Low Back Pain and Radiographic Features: A Systematic Review with Meta-Analysis
Abstract Number: 1575

The Association Between Obesity and Disease Phenotype in Psoriatic Arthritis
Abstract Number: 2021

The Association Between Rheumatoid Factor and Cardiovascular Disease in Healthy Adults
Abstract Number: 2079

The Association Between Straight Neck and Fibromyalgia
Abstract Number: 1370

The Association of Body Mass Index (BMI) and Radiographic Progression of Joint Disease in Rheumatoid Arthritis (RA)
Abstract Number: 451

The Association of Fine Specificities of Anti-Citrullinated Protein Antibodies (ACPA) with disease Severity in African-Americans with RA
Abstract Number: 1801

The Association of Knee Shape with Sex: The Osteoarthritis Initiative
Abstract Number: 1862

The Association of Low-Density Granulocytes with Disease Activity and Response to Treatment in ANCA-Associated Vasculitis
Abstract Number: 614

The Association of PPM1A with Inflammasome Activation in Ankylosing Spondylitis
Abstract Number: 1505

The Biosimilar Landscape: A Systematic Review of Its Current Status
Abstract Number: 1811

The Burden of Depression on Healthcare Utilization in a Population-Based Cohort of Patients with Systemic Lupus Erythematosus
Abstract Number: 2656

The Burden of Neuropsychiatric Symptoms in Systemic Lupus Erythematosus: Physician’s and Patient’s Perspectives
Abstract Number: 343

The Caspase 8/RIPK3 Signaling Axis Has Opposing Roles in Myeloid and Dendritic Cells during Progression of a Murine Model of Acute Inflammatory Arthritis
Abstract Number: 2865

The Cellular Effects of ANTI-Factor Xa Antibodies Isolated from Patients with Antiphospholipid Syndrome ARE Inhibited By Factorxa Inhibitors, Hydroxychloroquine and Fluvastatin
Abstract Number: 2881

The Center of Excellence in Musculoskeletal Care and Education: A Sustainable Interprofessional, Multidisciplinary Programmatic Innovation Developed with the Department of Veterans Affairs
Abstract Number: 2914

The Clinical and Radiographic Course of Early Undifferentiated Arthritis Under Treatment Is Not Dependent on the Amount of Erosions at Diagnosis. Results from the Swiss Prospective Observational Cohort
Abstract Number: 2749

The Clinical Course of Acute Deep Vein Thrombosis of the Legs in Behçet’s Syndrome
Abstract Number: 1659

The Clinical Relevance of a Repeat Biopsy in Lupus Nephritis (LN) Flares
Abstract Number: 593

The Clinimetric Outcomes of Two Bath Ankylosing Spondyltis Metrology Indices in Treatment with TNF-á Blockers
Abstract Number: 1821

The Co-Occurrence Patterns of MRI Lesions and Incident Knee Osteoarthritis: The MOST Study
Abstract Number: 645

The Combination of Metformin and 2-Deoxy-D-Glucose Normalizes CD4 T Cell Metabolism and Functions, and Reverse Disease in Murine Models of Lupus
Abstract Number: 2341

The Combination Therapy of Cell Cycle Regulation Therapy Combined and TNF Blockade Ameliorated the Established Arthritis
Abstract Number: 1110

The Comparative Efficacy of Kinesio Taping and Local Injection Therapy in Patients with Subacromial Impingement Syndrome
Abstract Number: 2562

The Comparative One-Year Drug Survival Rate of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid arthritis and ankylosing spondylitis; results from Turkbio Registry
Abstract Number: 424

The Comparison Between Physical and Ultrasound Joint Examination for the Hand Joints in Patients with Rheumatoid Arthritis
Abstract Number: 2632

The Cornerstone to Reasonable Allocation of Health Resource: Valuation of Health Utility in Systemic Lupus Erythematosus
Abstract Number: 2337

The Cost and Effectiveness of Various Recruitment Strategies in a Mind Body Clinical Trial Among Older Adults with Knee Osteoarthritis
Abstract Number: 2150

The Craniocervical Junction in Ankylosing Spondylitis: A Computed Tomography Based Study
Abstract Number: 2689

The CUL4^CRBN E3 Ubiquitin Ligase Modulator CC-220 Induces Degradation of the Transcription Factors Ikaros and Aiolos: Immunomodulation in Healthy Volunteers and Relevance to Systemic Lupus Erythematosus
Abstract Number: 234

The Decrease in Prescription of Anti-Osteoporotic Drugs Has No Impact on Hip Fracture Incidence
Abstract Number: 1921

The Deposition of Complement C4d Split Product on Platelets and Erythrocytes Correlate with Disease Activity and Improvement in Systemic Lupus Erythematosus
Abstract Number: 3010

The Development and Evaluation of a Self-Monitoring and Patient-Initiated Follow-up Service for People with Rheumatoid or Psoriatic Arthritis on Methotrexate
Abstract Number: 2799

The Differential Impact of Obesity on the Pathogenesis of RA or Preclinical Models Is Contingent on the Disease Status
Abstract Number: 2683

The Discovery of Novel Splicing Variants of Neurogranin and Their Role in the Pathogenesis of Systemic Lupus Erythematosus
Abstract Number: 2563

The Distribution of Inflammatory Lesions in the Anterior and Posterior Structures of the Spine in Patients with Active Ankylosing Spondylitis and the Effect of TNF-α-Blockade
Abstract Number: 2676

The E3 Ligase Casitas B Lineage Lymphoma b (Cbl-b) Modulates Peripheral Regulatory T Cell Function Via p27^kip1in Patients with Systemic Lupus Erythematosus
Abstract Number: 1260

The Early Use of Cyclosporine Is Beneficial for Long-Term Prognosis in Patients of Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease with Anti- Synthetase Antibodies
Abstract Number: 1587

The Economic Impact of Psoriatic Arthritis in Toronto, Ontario
Abstract Number: 2674

The Effect and Mechanisms of Icaritin on Regulating Foxp3/IL17a Expression in CD4⁺ T Cells from SLE
Abstract Number: 1750

The Effect of a Pro-Inflammatory Milieu on Tregalizumab (BT-061)-Induced Regulatory T-Cell Activity
Abstract Number: 2000

The Effect of a Rheumatology Ambulatory Rotation for Medical Residents on Documentation of Musculoskeletal Complaints
Abstract Number: 2527

The Effect of Biological Agents on Work in Patients with Chronic Inflammatory Arthritides: A Meta-Analysis of Randomized Controlled Trials and Controlled Cohorts
Abstract Number: 18

The Effect of Clinically Significant Antiphospholipid Antibody Positivity on Organ Damage in Systemic Lupus Erythematosus
Abstract Number: 2555

The Effect of Co-Medication with Conventional Synthetic (cs)Dmards on Achieving Low Disease Activity While Persisting on Adalimumab Therapy in Patients with Ankylosing Spondylitis/ Axial Spondylarthritis (AS)– Analysis from the Czech Biologics Registry Attra
Abstract Number: 2832

The Effect of Co-Medication with Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs on TNF Inhibitor Drug Survival in Patients with Ankylosing Spondylitis: Results from a Nationwide Prospective Study
Abstract Number: 981

The Effect of Compression Gloves in Hand Osteoarthritis: A Pre-Post-Test Trial
Abstract Number: 2565

The Effect of DMARD Co-Therapy on the Clinical Efficacy of Anti-TNF Medications in Patients with Axial Spondyloarthritis
Abstract Number: 1086

The Effect of Foot Pain on Mobility Disability in Older Adults: The Framingham Foot Study
Abstract Number: 1111

The Effect of High Intensity Laser Therapy in the Management of Myofascial Pain Syndrome of the Trapezius: A Double Blind, Placebo-Controlled Study
Abstract Number: 178

The Effect of Initiating Pharmacologic Insulin on Serum Uric Acid Levels in Patients with Diabetes
Abstract Number: 254

The Effect of Milnacipran on Pain in Rheumatoid Arthritis Patients with Widespread Pain: a Randomized Blinded Crossover Trial
Abstract Number: 643

The Effect of TNF Inhibition on the Autoreactive B Cell Repertoire in SLE Prone Mice
Abstract Number: 268

The Effect of Treatment with Resiniferatoxin and Capsaicin on Dynamic Weight Bearing Measures and Evoked Pain Responses in a Chronic Inflammatory Arthritis Murine Model
Abstract Number: 1105

The Effectiveness of Mirror Therapy in Patients with Adhesive Capsulitis
Abstract Number: 678

The Effectiveness of Tacrolimus for Minor Flares of the Patients with Systemic Lupus Erythematosus
Abstract Number: 1115

The Effects of Mulligan’s Mobilization with Movement Techniques in Patients with Lateral Epicondylitis
Abstract Number: 2250

The Effects of Treatment on Disease Symptoms and Progression of Structural Changes in Knee Osteoarthritis Participants from the Osteoarthritis Initiative Progression Cohort
Abstract Number: 1566

The Efficacy and Safety of Biological Disease Modifying Anti-Rheumatic Drugs and Apremilast in the Treatment of Psoriatic Arthritis: A Systematic Review and Meta-Analysis
Abstract Number: 2469

The Efficacy and Safety of Tocilizumab Subcutaneous Q2W and Following Escalation from Q2W to QW Therapy in Combination with Traditional Dmards in Patients with Moderate to Severe Rheumatoid Arthritis at 96 Weeks
Abstract Number: 1330

The Efficacy of a Multidisciplinary Intervention Strategy for the Treatment of Benign Joint Hypermobility Syndrome (BJHS) in Childhood: A Randomized, Single Center Parallel Group Trial
Abstract Number: 1879

The Efficacy of Pregabalin for Treating Fibromyalgia Patients with Moderate or Severe Baseline Widespread Pain
Abstract Number: 591

The Fat Spondyloarthritis Spine Score (FASSS) Independently Predicts Radiographic Progression in Patients with Ankylosing Spondylitis
Abstract Number: 895

The Fibromyalgia Syndrome and Widespread Pain Frequency in Active Duty U.S. Service Members with Posttraumatic Stress Disorder
Abstract Number: 2472

The First, Multicenter, Double-Blind, Randomized, Parallel-Group Study of Certolizumab Pegol in Early Rheumatoid Arthritis Demonstrates Inhibition of Joint Damage Progression
Abstract Number: 525

The Genetic Basis of Sjögren’s Syndrome (SS) Clinical Manifestations from Genome-Wide Association Analysis of Subphenotype Extremes in an International Cohort
Abstract Number: 1627

The Global Antiphospholipid Syndrome Score (GAPSS) Differentiates Between Transient Ischemic Attack and Stroke in Patients with Antiphospholipid Antibodies
Abstract Number: 754

The Global miRNA Whole Blood Profile in Systemic Sclerosis and Its Correlation with Serum Cytokine Levels
Abstract Number: 2902

The Health Status of Patients with Juvenile Idiopathic Arthritis (JIA) Significantly Worsens after Transfer from Pediatric to Adult Care
Abstract Number: 607

The HLA-B27 Peptidome in Vivo in Transgenic Rats
Abstract Number: 2905

The IL-6/Th17 Axis Promotes Autoantibody-Associated Autoimmune Valvular Carditis in Mice
Abstract Number: 606

The Immunological Basis of the Sex-Bias in Ankylosing Spondylitis: Th17 Expansion Is Restricted to Male Patients and Correlates with Sex-Related Alteration in Vitamin D Metabolism
Abstract Number: 41

The Impact of Ankylosing Spondylitis on Work Impairment: Data from the Scotland Registry for Ankylosing Spondylitis
Abstract Number: 2058

The Impact of Environmental Stress on Pain in Fibromyalgia Patients
Abstract Number: 2430

The Impact of Inadequate Health Literacy on Disease Activity in Patients with Rheumatoid Arthritis
Abstract Number: 371

The Impact of Missing Anti-Citrullinated Protein Antibody (ACPA) on Outcomes in Early Rheumatoid Arthritis: From the Canadian Early Arthritis Cohort
Abstract Number: 2955

The Impact of Northern European Ancestry and Susceptibility Loci on the Risk of Lupus Nephritis
Abstract Number: 2131

the Impact of Patient-Reported Flares on Radiographic Progression in Rheumatoid Arthritis Patients with Low-Disease Activity: Secondary Analyses from a Randomized Trial
Abstract Number: 767

The Impact of Plasmacytoid Dendiritc Cells (pDCs) on Fibrosis in bleomycin–induced Murine Model of Systemic Sclerosis (SSc)
Abstract Number: 2547

The Impact of Primary Sjögren’s Syndrome on Female Sexual Function
Abstract Number: 1378

the Impact of Rheumatoid Arthritis Activity and Medications on Pregnancy Outcomes
Abstract Number: 838

The Impact of Rheumatoid Arthritis Disease Activity on Cardiovascular Disease Risk: What Is the Role of the Flare?
Abstract Number: 626

The Impact of the Interaction Between Human Leukocyte Antigen Alleles and Obesity on Psoriatic Arthritis Risk
Abstract Number: 1515

The Impact on Anti-Citrullinated Protein Antibody Isotypes and Epitope Fine Specificity in Patients with Early RA Treated with Abatacept and Methotrexate
Abstract Number: 1783

The Importance of Histopathological Classification of ANCA-Associated Glomerulonephritis in Renal Function and Renal Survival
Abstract Number: 2746

The Importance of the Serum Visfatin Levels in Behcet’s Disease Patients
Abstract Number: 786

The Incidence and Mortality Rates of Giant Cell Arteritis in Southern Norway Are Lower Than Previous Reported
Abstract Number: 1850

The Incidence and Risk Factors for Psa in Patients with Psoriasis – a Prospective Cohort Study
Abstract Number: 2206

The Incidence of Zoster in Patients with Cutaneous Lupus Erythematosus and Dermatomyositis Is Increased Compared to the Average U.S. Population
Abstract Number: 1191

The Kimriss Bone Marrow Lesion Score in Patients with Osteoarthritis of the Knee Correlates with WOMAC Pain Status Using Target-Lesion Based Scoring Methodology; Data from the Osteoarthritis Initiative
Abstract Number: 1705

The Lectin Pathway of Complement – a Potential Role in the Pathogenesis and Disease Manifestations of Systemic Sclerosis
Abstract Number: 971

The Long-Term Efficacy of an Anti-Pneumococcal Polysaccharide Vaccine (PPSV23, Pneumovax) Among Autoimmune Inflammatory Rheumatic Patients
Abstract Number: 1434

The Longitudinal Association Between Inflammation and Blood Pressure in Rheumatoid Arthritis
Abstract Number: 1382

The Longitudinal Course of Fatigue in Rheumatoid Arthritis – Results from the Norfolk Arthritis Register
Abstract Number: 2075

The Lumbar Spine in Fibromyalgia
Abstract Number: 1125

The Mitochondrial Genome Influences the Risk of Incident Knee OA. DATA from the Osteoarthritis Initiative
Abstract Number: 2513

The Monitoring of Infliximab Levels at Early Stages Can Predict the Development of Anti-Infliximab Antibodies in a Cohort of Rheumatoid Arthritis Patients Treated with Infliximab
Abstract Number: 2179

The Monocyte-Phagocyte System in Gout: Enhanced Inflammasome Activity and Expansion of CD14++CD16+ Monocytes in Patients with Gout
Abstract Number: 1121

The mtDNA Haplogroups Influence the DNA Methylome of Articular Chondrocytes
Abstract Number: 450

The Mucosal Anti-Citrullinated Protein Antibody Response in Pre-Clinical Rheumatoid Arthritis
Abstract Number: 2973

The Multi-Biomarker Disease Activity Score As a Predictor of Radiographic Progression in a Registry of Patients with Rheumatoid Arthritis
Abstract Number: 1762

The Muscle Biopsy Is a Useful and Noninvasive Procedure in Diagnosing Systemic Vasculitis Affecting Small-to-Medium-Sized Vessels: A Prospective Evaluation
Abstract Number: 2001

The Musculoskeletal Mini-Residency Collaborative Network: A National Department of Veterans Affairs Interdisciplinary and Interprofessional Educational Innovation for Primary Care Providers
Abstract Number: 1286

The Natural Course of Physical Function in People with Symptomatic Knee Osteoarthritis: Data from the Osteoarthritis Initiative
Abstract Number: 2333

The Natural Use of Activity Pacing in Daily Life Does Not Result in Lower Symptoms in Osteoarthritis
Abstract Number: 2710

The New ACR-EULAR 2013 Systemic Sclerosis Classification Criteria Show Good Performance in a Capillaroscopy Clinic
Abstract Number: 2301

The New Proposal Classification Criteria for Juvenile Spondyloarthropaties
Abstract Number: 2353

The Nitric Oxide Receptor Soluble Guanylyl Cyclase Is Found in Lymphatic Vessels of Arthritic Mice and Inhibition Alters Lymphatic Pulse
Abstract Number: 2919

The Novel Rheumatoid Arthritis (RA) Risk Gene, LBH, Is Regulated By TGFß and PDGF and Modulates Cell Growth in Fibroblast-like Synoviocytes
Abstract Number: 2113

The Number of Morbidities Drives the Health Care Expenditures and Presence of a Musculoskeletal Condition Is Additionally Accountable for Higher Costs
Abstract Number: 70

The Odds of Work Disability, Unemployment and Depending on Living Allowances Are More Influenced By the Number of Morbidities Than By the Presence of a Musculoskeletal Disease
Abstract Number: 664

The Pathogenesis of Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Brain Intrinsic Factors
Abstract Number: 1708

The Pathogenic Role of Immune Complexes Containing Scleroderma-Specific Autoantibodies in the Inductor Phase of the Disease
Abstract Number: 2328

The Physical and Psychosocial Effects of Exercise on Chronic Hip and Knee Pain: A Cochrane Review with Meta-Analysis
Abstract Number: 628

The Predictive Value of Cardiovascular and Metabolic Biomarkers for Progression of Atherosclerosis in Psoriatic Disease
Abstract Number: 2294

The Presentation and Initial Treatment of Systemic Juvenile Idiopathic Arthritis According to Observational Data from the United States and the United Kingdom
Abstract Number: 42

The Prevalence of Ankylosing Spondylitis in Sweden – a Nationwide Register Study
Abstract Number: 1087

The Prevalence of Knee Arthritis and Associated Self-Reported Limitation of Activity in Chinese Populations
Abstract Number: 1244

The Prevalence of Malignancy in Adult-Onset Still’s Disease
Abstract Number: 1413

The Prevalence of Renal Impairment in Patients with Rheumatoid Arthritis
Abstract Number: 1247

The Prevalence of Sacroiliitis and Spondyloarthritis in Patients with Sarcoidosis
Abstract Number: 1161

The Price of a Positive Test: Is It Worth the Cost?
Abstract Number: 1977

The Proangiogenic Function of the Epigenetic Regulator EZH2 in Synovial Tissue Is Mediated By Fibroblasts in Rheumatoid Arthritis
Abstract Number: 2638

The Protective Effects of Statins for Thrombosis in Patients with Systemic Lupus Erythematosus Positive for Antiphospholipid Antibodies
Abstract Number: 1302

The Psychological Impact on Health-Related Quality of Life in Childhood-Onset Lupus
Abstract Number: 1217

The Random Urine Uric Acid to Creatinine Ratio As a Predictor of 24-Hour Urine Uric Acid Excretion in Gout Patients
Abstract Number: 715

The REAL Life with Lupus Study: Developing a Patient Reported Outcome Measure for Use in Clinical Trials and Clinical Care
Abstract Number: 1218

The Reduction of Serum Uric Acid Level Might Prevent Atherosclerosis in Mice
Abstract Number: 1083

The Relation of Step Length to MRI Features of Osteoarthritis in the Patellofemoral Joint: The MOST Study
Abstract Number: 404

The Relationship Between Disease Activity and Levels of HMGB1 in Patients with Rheumatoid Arthritis
Abstract Number: 1216

The Relationship Between Serum Homocysteine, Uric Acid and Renal Function in Chronic Gouty Patients: 2 Year Follow-up Results
Abstract Number: 1120

The Relationship Between Tender Points and Disease Severity in Patients with Fibromyalgia
Abstract Number: 1711

The Relationship Between Vascular Biomarkers and Disease Characteristics in Systemic Sclerosis: Elevated MCP-1 Is Associated with Predominantly Fibrotic Manifestations
Abstract Number: 2851

The Relationship of ARMS2 Genotype with Idiopathic Inflammatory Vasculitis
Abstract Number: 2713

The Relationship of Patient Reported Skin Symptoms to the Scleroderma HAQ, the Modified Rodnan Skin Score and Skin Pathology.
Abstract Number: 217

The Relationship of Quadriceps and Hamstrings Intramuscular Fat and Lean Muscle with Power in Women with Knee Osteoarthritis
Abstract Number: 2892

The Relative Risk of Incident NON-Ischemic Heart Failure in Prevalent Rheumatoid Arthritis
Abstract Number: 1666

The Relevance of Urinary Podocyte Number and Urinary Podocalyxin Level with Response to Treatment and 1 Year Renal Prognosis in Systemic Lupus Erythematosus
Abstract Number: 2288

The Research in Arthritis in Canadian Children Emphasizing Outcomes (ReACCh Out) Cohort: Independent Risk Factors and Medication Use in New Onset Uveitis in Juvenile Idiopathic Arthritis
Abstract Number: 3013

The Reserve Capacity Model in Patients with Rheumatoid Arthritis: Understanding the Relationship of Socioeconomic Status, Psychosocial Resources, Mood, and Pain
Abstract Number: 2957

The Rheumatoid Arthritis -Risk Locus CCR6 and Its SNP-Dependent Response to Estrogen: A Possible Genomic Link Between Sex Hormones and the IL-17 Inflammatory Pathway
Abstract Number: 356

The Rheumatoid Arthritis Impact of Disease Score Is Associated with Disease Activity By Clinical, Laboratory and Ultrasonographic Measures: Validation in an inception Cohort of DMARD naïve Patients with Rheumatoid Arthritis
Abstract Number: 47

The Risk of Aplastic Anemia and Pancytopenia with Colchicine: A Retrospective Study of Integrated Health System Database
Abstract Number: 845

The Risk of Cancer with Tumor Necrosis Factor Inhibitors in Patients Concomitantly Exposed to Non-Biological Immunosuppressants Differs According to the Indication
Abstract Number: 1624

The Role of B Lymphocyte Stimulator in Monocyte Subpopulation Differentiation in SLE
Abstract Number: 2361

the Role of CD146 in the Therapeutic Potential of Mesenchymal Stem Cells in Favor of CD146⁺ Cells for Experimental Arthritis
Abstract Number: 2358

The Role of Dendritic Cells during Inflammatory Arthritis
Abstract Number: 2741

The Role of Fli1 in Lupus T Cell Function and Nephritis
Abstract Number: 2610

The Role of IL-20 in the Pathogenesis of Ankylosing Spondylitis with Peripheral Joint Involvement
Abstract Number: 1861

The Role of Macrophage Migration Inhibitory Factor (MIF) and MIF Gene Polymorphisms in the Pathogenesis of Granulomatosis with Polyangiitis
Abstract Number: 2447

The Role of TET3-Mediated DNA Demethylation By Pro-Inflammatory Cytokines in Rheumatoid Arthritis
Abstract Number: 1971

The Role of the Proinflammatory Mediator High-Mobility Group Box Protein 1 (HMGB1) in Anti-Collagen-Antibody-Induced Arthritis Is Dependent on Vascular Endothelial Growth Factor (VEGF)
Abstract Number: 1210

The Role of the Transcription Factor cAMP Responsive Element Binding Protein 1 in Lipopolysaccharide-Induced Tolerance
Abstract Number: 516

The Safety and Treatment Efficacy of Abatacept in Rheumatoid Arthritis Patients with Pulmonary Complications: From the Tsurumai Biologics Communication Registry (TBCR) Multicenter Study
Abstract Number: 873

The Second Messenger, Cyclic GMP-AMP Dinucleotide (cGAMP) and the Enzyme, Cyclic GMP-AMP Synthase (cGAS), Are Expressed in Systemic Lupus Erythematosus
Abstract Number: 2675

The Selective Loss of SLAMF4⁺ CD8⁺ T Cells Contributes to the Decreased Cytotoxic Capacity Observed in Systemic Lupus Erythematosus
Abstract Number: 910

The Selective Sphingosine-1- Phosphate Receptor 1/5 Modulator Siponimod (BAF312) Shows Beneficial Effects in Patients with Active, Treatment Refractory Polymyositis and Dermatomyositis: A Phase IIa Proof-of-Concept, Double-Blind, Randomized Trial
Abstract Number: 2536

The Sjögren’s Syndrome Responder Index, a Data-Driven Combined Endpoint, Could Detect Biologics Efficacy
Abstract Number: 454

The Specificity of Anti-Carbamylated Protein Antibodies for Rheumatoid Arthritis in a Setting of Early Arthritis
Abstract Number: 1567

The Spectrum of Autoimmune Ophthalmic Manifestations in Psoriatic Disease
Abstract Number: 1794

The Sting Pathway Regulates Bone Remodeling in a Model of Autoimmune Disease
Abstract Number: 1549

The Swedish Early Psoriatic Arhtritis (SWEPSA) Registry 5-Yeear Follow-up: Slow Radiographic Progression with Highest Scores in Male Feet and in Patients with Baseline X-Ray Abnormalities
Abstract Number: 1725

The SYK Inhibitor Fostamatinib Limits Tissue Damage and Fibrosis in a Bleomycin-Induced Scleroderma MOUSE MODEL
Abstract Number: 2718

The UCLA Gastrointestinal Tract Questionnaire (GIT)2.0 and GI Visual Analogue Scale(GI-VAS) Reflect Different Aspects of GI Involvement in Systemic Sclerosis
Abstract Number: 2963

The URAT1 Uric Acid Transporter Is Important in Uric Acid Homeostasis and Its Activity May be Altered in Gout Patients and in Drug-Induced Hyperuricemia
Abstract Number: 2772

The Use of Imaging in the Diagnosis of Polymyalgia Rheumatica: Systematic Literature Review and Meta-Analysis
Abstract Number: 452

The Use of Multiplex Bead Array to Follow the Effect of Rituximab on IgG and IgA Serum Autoantibody Responses to Citrullinated Epitopes in Patients with Rheumatoid Arthritis
Abstract Number: 36

The Use of Three-Dimensionally Printed β-Tricalcium Phosphate/Hydroxyapatite to Further Understand the Regulation of Adenosine Receptors in Osteoclast Formation and Promotion in Bone Regeneration
Abstract Number: 122

The Use of Ultrasound to Detect Residual Joint Inflammation in Patients with Rheumatoid Arthritis in Clinical Disease Remission
Abstract Number: 378

The Use of Week 12 CDAI, RAPID3 and DAS28(CRP) Responses to Predict Optimal Response to Methotrexate
Abstract Number: 2126

The Utility of Digital Activity Fluorescence Optical Imaging in Quantifying Hand and Wrist Inflammation in Rheumatic Diseases
Abstract Number: 406

The Utility of HLA-DR Genotypification As a Complementary Tool to Discriminate Undifferentiated and Rheumatoid Arthritis Patients in Early Arthritis
Abstract Number: 714

The Validity of Patient and Physician Global Disease Activity Assessments of Systemic Lupus Erythematosus: Results from the Lupus Activity Scoring Tool (LAST) As Compared to the Selena Sledai (SS) Modification Multicentre Study
Abstract Number: 1930

The Value of Repeated Nailfold Capillaroscopy in Raynaud’s Phenomenon in Daily Practice: A Follow-up Study in the Netherlands
Abstract Number: 1444

The Vocational Experiences of Young People with Juvenile Idiopathic Arthritis and the Role of the Multidisciplinary Team Supporting Positive Employment Outcomes
Abstract Number: 2819

The YAP Pathway Regulates Fibroblast-like Synoviocyte Invasion
Abstract Number: 2347

Therapeutic Effect of a Novel Histone Deacetylase 6 Inhibitor, CKD-L, on Collagen Induced Arthritis and Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis
Abstract Number: 2343

Therapeutic Effects of Mesenchymal Stem Cells, Anti-Tumor Necrosis Factor and Anti-CD20 Treatment on Collagen Induced Arthritis
Abstract Number: 1512

Therapeutic Efficacy of a Novel Oral Small Molecule Macrophage Migration Inhibitory Factor [MIF] Inhibitor: A Promising Safe & Efficacious Treatment for Rheumatoid Arthritis
Abstract Number: 1726

Therapeutic Efficacy of Mesenchymal Stem Cells in Diffuse Murine Hypochlorite-Induced Systemic Sclerosis
Abstract Number: 1034

Therapeutic Potential of Targeting Sialic Acid Modified Receptors in Osteoarthritis
Abstract Number: 558

Therapeutic Response in Adalimumab-Treated Patients with Non-Radiographic Axial Spondyloarthritis Is Similar Regardless of Body Mass Index
Abstract Number: 573

Three-Year Course and Prediction of Physical Functioning in Ankylosing Spondylitis Patients Treated with TNF-Inhibitors
Abstract Number: 2

Thrombocytopenia in Primary Antiphospholipid Syndrome Is Related to Arterial Thrombosis
Abstract Number: 1634

Thrombophilia Associated with DFS70 Antibodies
Abstract Number: 1980

Thrombospondin-1 Is Elevetad in the Plasma of Patients with Antiphospholipid Syndrome and Is Correlated with Soluble Fas Ligand and Free Active TGF-B levels
Abstract Number: 1654

Thrombotic Microangiopathy and Poor Renal Outcome in Lupus Patients Is Not Associated with Antiphospholipid Syndrome and/or Other Lupus Conventional Features
Abstract Number: 1052

Time Trends in Comorbidities Among Patients with Rheumatoid Arthritis Compared to the General Population
Abstract Number: 188

Time Trends in Total Ankle Arthroplasty in the U.S.: A Study of the Nationwide Inpatient Sample
Abstract Number: 2814

Time-to-Remission, Time-to-Relapse and Disease Severity at the Time of Relapse in RA- Results from the Ontario Best Practices Research Initiative (OBRI)
Abstract Number: 1452

Timing of Decisions to Adjust Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy for Rheumatoid Arthritis (RA) Patients with Active Disease in a Usual Practice Setting
Abstract Number: 192

Title: Use of Non-Traditional Modalities for Pain Management after Knee or Hip Joint Replacement
Abstract Number: 1722

TLR4 and TLR7 Are Required for Gadolinium Based Contrast Agent Induction of Dermal and Pulmonary Fibrosis in an Adenine-Induced Model of Chronic Renal Failure
Abstract Number: 2869

TLR7 Influences Autoreactive B Cell Selection in the Germinal Center
Abstract Number: 2274

TNF Inhibitors Provide Long-Term Clinical Benefits in 6 Patients with Early-Onset Sarcoidosis
Abstract Number: 1035

TNF-á Modulates the Expression of Circadian Clock Genes Via Calcium Signaling in Rheumatoid Synovial Cells
Abstract Number: 1516

TNF-Alpha Inhibitors Normalizes Melanocortin Receptor Subtype 2, 3 and 4 Expression in CD8+, CD14+ and CD19+ Leukocyte Subsets in Rheumatoid Arthritis
Abstract Number: 1471

TNFα Influences the Status of B and T Cells By Acting on BCR and TCR Pathways Via RasGRP1 and RasGRP3 Proteins
Abstract Number: 2729

To Live or Let Die… the Battle Between PD-1 and OX40 on SLE T Cells
Abstract Number: 1763

Tobacco Differentially Affects the Clinical-Biological Phenotype of ANCA-Associated Vasculitides at Diagnosis
Abstract Number: 1233

Tocilizumab (TCZ) in the Treatment of AA Amyloidosis in Patients with Familial Mediterranean Fever
Abstract Number: 1845

Tocilizumab Combination Therapy or Monotherapy or Methotrexate Monotherapy in Methotrexate-Naive Patients with Early Rheumatoid Arthritis: 2-Year Clinical and Radiographic Results from a Randomized, Placebo-Controlled Trial
Abstract Number: 814

Tocilizumab in Giant Cell Arteritis: Multicenter Open-Label Study of 22 Patients
Abstract Number: 2508

Tocilizumab Serum Trough Levels and Its Relationship with Disease Activity and Drug Dosage in Rheumatoid Arthritis Patients
Abstract Number: 1912

Tocilizumab Therapy for Rheumatoid Arthritis Patients with Chronic Renal Insufficiency
Abstract Number: 2296

Tocilizumab Therapy in Children with Systemic Juvenile Idiopathic Arthritis. DATA from Russian Register of Sjia
Abstract Number: 502

Tocilizumab Use in Patients with Rheumatoid Arthritis Having Failed One Previous Anti-TNF Agent: Comparison with Adalimumab, Etanercept and Infliximab
Abstract Number: 2910

Tofacitinib Facilitates the Expansion of Myeloid-Derived Suppressor Cells and Ameliorates Arthritis in SKG Mice
Abstract Number: 486

Tofacitinib Improves Arterial Stiffness Despite up-Regulating Serum Cholesterol with Chronic Cardiovascular Disease in Methotrexate-Resistant Active Rheumatoid Arthritis Patients. a Cohort Study
Abstract Number: 2800

Tofacitinib Regulates Synovial Angiogenesis in Psoriatic Arthritis through Induction of Negative Feedback Inhibitors
Abstract Number: 849

Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension up to 6 Years
Abstract Number: 2909

Tolerogenic Splenic IDO+ Dendritic Cells from the Mice Treated with Induced-Treg Cells Could Suppress Collagen-Induced Arthritis
Abstract Number: 779

Toll-like Receptor 2 Agonism Induces Inflammation, Angiogenesis and Cell Migration in Giant Cell Arteritis
Abstract Number: 1816

Toll-like Receptor 4-Induced Interleukin-1 Defines the Intestinal Microbiome and Mucosal Immune Response in Arthritis-Prone IL-1 Receptor Antagonist Deficient Mice
Abstract Number: 339

Toll-like Receptor Dependent Autoantigens and Vesicles from P.Gingivalis in Animal Models of RA to Modulate Collagen and Collagen Antibody Induced Arthritis
Abstract Number: 2356

Toluenesulfonylamido-Chalcone, 4-(p-toluenesulfonylamido)-4-Hydroxychalcone (TSAHC) Suppresses Inflammatory Response and Joint Destruction in an Experimental Arthritic Mice and Fibroblast-like Synoviocytes
Abstract Number: 2317

Towards Reliable Implementation and Optimal Use of Medication Decision Aid Cards for Shared Decision Making in Juvenile Idiopathic Arthritis
Abstract Number: 1301

Trabecular Bone Impairment Assessed By HR-pQCT in Juvenile-Onset Systemic Lupus Erythematous with Vertebral Fractures
Abstract Number: 898

Traditional Cardiovascular Risk-Factor Management in Patients with Rheumatoid Arthritis Compared with Matched Non-Rheumatoid Arthritis Patients in a US Managed Care Setting
Abstract Number: 2884

Training the Rheumatologists of Tomorrow: The Canadian Experience
Abstract Number: 1085

Trajectories and Predictors of Physical Activity over Two Years in Rheumatoid Arthritis
Abstract Number: 1089

Trajectories of Disability over Time Among Patients with Systemic Sclerosis
Abstract Number: 1136

Transcriptional Heterogeneity of the SLC2A9 Gene Encoding the GLUT9 Urate Transporter
Abstract Number: 768

Transforming Growth Factor Beta Induces anti Angio and Vasculo-Genesis Phenotype in Dermal Fibroblasts through Secretion of Pigment Epithelium Derived Factor
Abstract Number: 1967

Transforming Growth Factor Beta Is a Major Regulator of Micro-RNA Synthesis in Rheumatoid Arthritis Synovial Fibroblasts
Abstract Number: 1326

Transition of Care and Long-Term Outcomes of Juvenile Systemic Sclerosis during Adulthood: Results from a French Single-Center Case-Control Study
Abstract Number: 557

Translation and Cross-Cultural Adaptation of the ASAS Health Index and the environmental Item Set into 15 Languages
Abstract Number: 1731

Translocation of IGFBP-5 to the Nucleus and Its Interaction with Nucleolin Do Not Dictate Its Fibrotic Effects
Abstract Number: 1122

Transmitocondrial Cybrids: A Tool to Study the Role of mtDNA Haplogroups in OA Pathogenesis
Abstract Number: 1021

Transthyretin and Amyloid in Cartilage Aging and Osteoarthritis
Abstract Number: 2396

Treat to Target in Routine Clinical Practice
Abstract Number: 114

Treat-to-Target (T2T) and Measuring Outcomes in RA Care: a 2014 Longitudinal Survey of US Rheumatologists
Abstract Number: 2609

Treating Axial-Spa to Target: Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) Inactive Disease in a Cohort of Patients Treated with Anti-TNFα Agents
Abstract Number: 2483

Treatment Adjustment Strategy after Achieving Remission or Low Disease Activity in Rheumatoid Arthritis : A Systematic Review and Meta-Analysis
Abstract Number: 2026

Treatment Delays and Worse Outcomes Associated with Lower Socioeconomic Status in Rheumatoid Arthritis
Abstract Number: 1548

Treatment Effect of Ustekinumab on Fatigue in Patients with Psoriatic Arthritis: Results from a Phase 3 Clinical Trial
Abstract Number: 346

Treatment of Collagen Induced Artritis with Human Embrionic Stem Cell-Derived Multipotent Mesenchymal Stromal Cells (hESC-MSC)
Abstract Number: 1095

Treatment of Fibromyalgia with Neurostimulation: A Randomized, Double-Blinded, Sham-Controlled Trial
Abstract Number: 2756

Treatment of Mucocutaneous Manifestations in Behçet’s Disease with Anakinra: A Pilot Open-Label Study
Abstract Number: 1494

Treatment of Rheumatoid Arthritis Patients with the JAK1-Selective Inhibitor GLPG0634 Reverses an Arthritis-Specific Blood Gene Signature to Healthy State
Abstract Number: 1684

Treatment of Scleroderma Associated Lung Disease with Mycophenolate Mofetil: A Community-Based Study
Abstract Number: 2230

Treatment of Symptomatic Knee Osteoarthritis with Oral Salmon Calcitonin: Results from Two Phase 3 Randomized Clinical Trials
Abstract Number: 2418

Treatment Pattern and Direct Cost of Biologics for Rheumatoid Arthritis Patients: A Real-World Analysis of Nationwide Japanese Claims Data
Abstract Number: 2623

Treatment Patterns and Resource Utilization of Systemic Lupus Erythematosus Patients Newly Initiating Standard of Care: United States Commercial and Medicare Supplemental Claims Analysis
Abstract Number: 1540

Treatment Patterns of Biologics Used in Rheumatoid Arthritis and Ankylosing Spondylitis in the US Veterans Population
Abstract Number: 2029

Treatment Patterns of Multimorbid Rheumatoid Arthritis Patients: Results from an International Cross-Sectional Study
Abstract Number: 274

Treatment Prescribing Patterns in a Cohort of Patients with Juvenile Idiopathic Arthritis (JIA). Data from the Childhood Arthritis Prospective Study
Abstract Number: 2470

Treatment Strategy for Maximizating the Effect of Adalimumab in Japanese Patients with Rheumatoid Arthritis : Retrospective Analyses of Data Collected from the Patient Treated with Adalimumab in Routine Clinical Practice in Hamamatsu Area
Abstract Number: 642

Treatment with a Glycolipid Ameliorates Lupus Dermatitis and Expands Skin ãä T Cells That Promote the Migration of Langerhans Dendritic Cells
Abstract Number: 875

Treatment-Related Outcomes in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A Pooled Analysis of 12 Randomized Controlled Trials
Abstract Number: 2196

Treprostinil Use in Malignant Atrophic Papulosis (Köhlmeier-Degos Disease): Review of Worldwide Experience to Date
Abstract Number: 506

Trial of Six Weeks Interval of Tocilizumab Infusion in Patients with Rheumatoid Arthritis
Abstract Number: 816

TRNT1 Missense Mutations Define a New Periodic Fever Syndrome
Abstract Number: 738

Troponin T as a Diagnostic and Prognostic Biomarker of Primary Cardiac Involvement in Systemic Sclerosis
Abstract Number: 2042

Tuberculin Conversion in Patients with Autoimmune Arthropathies Receiving Biologic Therapy
Abstract Number: 2157

Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases
Abstract Number: 2959

Twenty-Eight Loci That Influence Serum Urate Levels: Analysis of Association with Gout
Abstract Number: 2095

Two Novel Serum Urate Levels Associated Genetic Loci Identified By GWAS in European Were Confirmed in Chinese Han Population
Abstract Number: 540

Two Years Sacroiliac Radiographic Progression Rate and Influence of Baseline Markers of Inflammation in Recent Onset Spondyloarthritis
Abstract Number: 1047

Type I and II Interferon Signatures in Sjogren’s Syndrome: Contributions in Distinct Clinical Phenotypes and Sjogren’s Related Lymphomagenesis
Abstract Number: 654

Type I Interferon Induces the Depletion and Dysfunction of Endothelial Progenitor Cells in Gld. ApoE-/- C57BL/6 Mice
Abstract Number: 1202

Type I Interferon Promotes Inflammatory Cytokine Production By Inhibiting Mir-146a Maturation in SLE